Improving the N-glycosylation occupancy of plant-produced IgG1 by engineering the amino acid environment at Asn297
Monoclonal antibodies are crucial recombinant biopharmaceuticals, with N-glycosylation at Asn297 essential for their functionality. Plants are increasingly used for antibody production, achieving high expression levels and enabling glycoengineering to produce homogenous human-like N-glycan structure...
Saved in:
Main Authors: | Kathrin Göritzer, Valentina Ruocco, Ulrike Vavra, Shiva Izadi, Omayra C. Bolaños-Martínez, Thareeya Phetphoung, Nuttapat Pisuttinusart, Waranyoo Phoolcharoen, Richard Strasser |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Plant Science |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpls.2024.1531710/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quantitative N-glycoproteomic analysis reveals glycosylation signatures of plasma immunoglobulin G in systemic sclerosis
by: Lu Cheng, et al.
Published: (2025-02-01) -
Association between elevated glycosylated hemoglobin levels and hypertension among US adults: NHANES 2011–2018
by: Beibei Luo, et al.
Published: (2025-01-01) -
Genetic control of N-glycosylation of human blood plasma proteins
by: S. Zh. Sharapov, et al.
Published: (2023-06-01) -
Synergistic effects of mutation and glycosylation on disease progression
by: Shodai Suzuki, et al.
Published: (2025-02-01) -
Developing glycoproteomics reveals the role of posttranslational glycosylation in the physiological and pathological processes of male reproduction
by: Qingyuan Cheng, et al.
Published: (2024-09-01)